rosuvastatin
Not Tagged
[]
n=199, randomized single blind lipid, hscrp, cmp. baseline and at 28 days. 1 risk, age 40-75, ldl-c 70-189, borderline to upper intermediate risk (5-20%, estimated 10 yr event) 1 endpt: %ldl-c change vs rosuva 2 endpt: biomarkers vs rosuva; vs placebo
#aha22 2/ 
Associate Professor @intermountain; Faculty @rmuohp; President, @apac_Cardiology. follow/favorite ? endorse. Tweets, my view. #PAsInCardiology #PAtientHealth